Achilles Tendon Elongation and Gait Pattern After Rupture.

Achilles Tendon Rupture Clinical Trial

Official title:

Achilles Tendon Elongation and Gait Pattern After Rupture: A Three Armed Randomized Controlled Trial Comparing an Individualized Treatment Algorithm vs. Operative or Non-operative Treatment.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03543943
• Other study ID #: Achilles HVH RCT
• Status: Completed
• Phase: N/A
• Start date: June 4, 2018
• Est. completion date: December 10, 2020

Study information

• Verified date: March 2022
• Source: Hvidovre University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The objective of this study is to determine if Achilles tendon elongation and gait pattern differ between patients treated using an individualized treatment algorithm and patients treated as usual (two control groups; patients treated operatively and non-operatively).

The individualized treatment algorithm is based on ultrasonographic status of tendon overlap and Copenhagen Achilles Length Measure (1). Patients are allocated for operative treatment if there the tendon overlap is less than 25 % or the tendon is elongated with 7% or more compared to the healthy, contralateral achilles tendon.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 10, 2020
• Est. primary completion date: December 10, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Appointment in the Outpatients Department within 4 days of injury.

• Total Achilles tendon rupture.

• Initial treatment with split cast with the ankle in maximal plantar flexion must be started within 24 hours of injury.

• The patient must be expected to be able to attend rehabilitation and postexamination.

• The patient must be able to speak and understand Danish.

• The patient must be able to give informed consent.

Exclusion Criteria:

• Rupture of the Achilles tendon either at the insertion on the calcaneus or at musculotendinous junction of the triceps surae.

• Previous rupture of the Achilles tendon in any of the two legs.

• Treated with fluoroquinolones or corticosteroids within the last 6 months.

• In medical treatment of diabetes.

• Suffers from rheumatic disease.

• Other conditions prior to the injury resulting in reduced function of any of the two legs.

• Contra-indication for surgery: severe arthrosclerosis with no palpable pulse in the foot, broken skin in the Achilles region of the injured leg.

• Inability to lie in prone position on the operating table.

• Terminal illness or severe medical illness: American Society of Anaesthesiologists physical status classification score higher than or equal to 3.

Related Conditions & MeSH terms

• Achilles Tendon Rupture
• Rupture

Intervention

Procedure:
• Individualized treatment of Acute Achilles tendon rupture.
The most proximal border of the calcaneus and the most distal point of the musculotendinous junction of the medial gastrocnemius muscle is identified and marked on the skin. These two points on the un-injured leg defines the original length of the total Achilles tendon [1]. The difference in length between the injure and the un-injured leg determines elongation for the ruptured Achilles tendon. The relative elongation of the ruptured tendon together with overlap of the tendon ends on the cross-sectional area determines the treatment for the patients receiving individualized treatment: 1) patients with 0-6% elongation of the tendon and a minimum of 25% tendon are treated non-operatively 2) patients with 7% elongation or more or less than 25% tendon overlap are treated operatively.
• Non-operative treatment
Circulated cast below the knee in maximal, unforced plantar flexion over the ankel.
• Operative treatment
Open surgery with suture of the ruptured achilles tendon prior to circulated cast below the knee in maximal, unforced plantar flexion over the ankel.

Locations

Country	Name	City	State
Denmark	Department of Physiotherapy and Orthopedical surgery, Copenhagen University Hospital, Amager-Hvidovre	Copenhagen	Hvidovre

Sponsors (1)

Lead Sponsor	Collaborator
Hvidovre University Hospital

Country where clinical trial is conducted

Denmark, 

References & Publications (1)

Barfod KW, Riecke AF, Boesen A, Hansen P, Maier JF, Døssing S, Troelsen A. Validation of a novel ultrasound measurement of achilles tendon length. Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3398-406. doi: 10.1007/s00167-014-3175-2. Epub 2014 Jul 20. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Three-Dimensional Gait Analysis: Ankle peak power during push-off.	Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers. The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory. Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.	12 months after started treatment.
Secondary	Copenhagen Achilles Length Measure	The examination of both the total and the free part of the achilles tendon of both the injured and un-injured leg is performed. The total length of the tendon is defined under the description of the intervention. The free part of the achilles tendon is defined as the distance between the proximal border of calcaneus and the musculotendinous junction of the soleus muscle and the achilles tendon. The method will be used both diagnostically for the individualized treatment and as a secondary endpoint.	6 and 12 months after started treatment.
Secondary	Three-Dimensional Gait Analysis: Ankle peak power during push-off	Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers. The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory. Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.	6 months after started treatment.
Secondary	Three-Dimensional Gait Analysis: Maximal dorsiflexion in the stance phase.	Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers. The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory. Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.	6 and 12 months after started treatment.
Secondary	Three-Dimensional Gait Analysis: stiffness of the plantar flexor musculo-tendinous complex during dorsiflexion.	Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers. The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory. Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.	6 and 12 months after started treatment.
Secondary	Three-Dimensional Gait Analysis: time of heel-lift	Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers. The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory. Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.	6 and 12 months after started treatment.
Secondary	Three-Dimensional Gait Analysis: jumping up and down	Reflective markers placed on the patients skin with tape on specific anatomical locations, in total 19 markers. The reflective markers are being filmed by 8 infrared cameras hanging on the walls around the laboratory. Thereby, the joint angles during gait will be measured, and, in combination with the ground reaction forces from two force plates embedded in the floor, the joint moments and powers will be calculated.	6 and 12 months after started treatment.
Secondary	Balance measurement	The postural sway with patient standing on a force plate in the gait laboratory.	6 and 12 months after started treatment.